Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry

Clinical implications of systemic atherosclerosis in patients with cardiogenic shock (CS) remain unclear. This study investigated the association between polyvascular disease (PVD) and clinical outcome in CS patients. A total of 1247 CS patients was enrolled from the RESCUE registry, a multicenter,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cardiology 2021-09, Vol.339, p.70-74
Hauptverfasser: Jang, Woo Jin, Park, Ik Hyun, Yang, Jeong Hoon, Chun, Woo Jung, Oh, Ju Hyeon, Park, Yong Hwan, Ko, Young-Guk, Yu, Cheol Woong, Kim, Hyun-Joong, Kim, Bum Sung, Lee, Hyun Jong, Jeong, Jin-Ok, Gwon, Hyeon-Cheol
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Clinical implications of systemic atherosclerosis in patients with cardiogenic shock (CS) remain unclear. This study investigated the association between polyvascular disease (PVD) and clinical outcome in CS patients. A total of 1247 CS patients was enrolled from the RESCUE registry, a multicenter, observational cohort between January 2014 and December 2018. They were divided into two groups according to presence of PVD, defined as ≥2 coexistence of coronary artery disease, peripheral arterial disease, or cerebrovascular disease. Primary outcome was all-cause death during 12 months of follow-up. 136 (10.9%) patients were diagnosed with PVD. The risk of 12-month all-cause death was significantly higher in the PVD group than in the non-PVD group (54.4% versus 40.4%, adjusted hazard ratio [HR] 1.31, 95% confidence interval [CI] 1.02–1.69, p = 0.034). There was a significant interaction between PVD and vasoactive inotropic score (VIS) (p for interaction = 0.014). Among the 945 patients with VIS
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2021.07.008